Infectious diseases are thought to account for nearly 25% of all deaths worldwide, and extract a disproportionate toll in developing countries1. Moreover, infectious diseases are now appreciated to be major causes of the poverty and economic underdevelopment that characterize the world's poorest countries2. Development and deployment of new vaccines to prevent infectious diseases in developing countries have therefore become high priorities in the global health agenda.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The potential impact of immunization campaign budget re-allocation on global eradication of paediatric infectious diseases
BMC Public Health Open Access 28 September 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
World Health Organization. The World Health Report (World Health Organization, Geneva, 2003).
Sachs, J. Bull. World Health Organ. 80, 167–169 (2002).
National Institute of Allergy and Infectious Diseases, National Institutes of Health. The Jordan Report. 20th Anniversary: Accelerated Development of Vaccines. 261 (National Institutes of Health, Bethesda, Maryland, USA, 2002).
Hardon, A. & Blume, S. Soc. Sci. Med. 60, 345–356 (2005).
Milstein, J. & Belgharbi, L. Bull. World Health Organ. 82, 128–133 (2004).
Mahoney, R. & Maynard, J. Vaccine 17, 646–652 (1999).
Batson, A., Glass, S. & Seiguer, E. in The Vaccine Book (eds. Bloom, B. & Lambert, P.-H.) 345–370 (Academic Press, London, 2003).
Gotuzzo, E. et al. Infect. Immun. 61, 3994–3997 (1993).
John, T.J. & Jayabal, P. Am. J. Epidemiol. 96, 263–269 (1972).
Hanlon, P. et al. Lancet 329, 1342–1345 (1987).
Webber, D. & Kremer, M. Bull. World Health Organ. 79, 735–741 (2001).
Widdus, R. Bull. World Health Organ. 79, 713–720 (2001).
Alonso, P. et al. Lancet 364, 1411–1420 (2004).
Martin, J.F. & Marshall, J. Vaccine 21, 587–592 (2003).
Esparza, J. & Osmanov, S. Curr. Mol. Med. 3, 183–193 (2003).
Glass, R.I., Bresee, J.S., Parashar, U.D., Jiang, B. & Gentsch, J. Lancet 363, 1547–1550 (2004).
Salisbury, D. Pediatr. Infect. Dis. J. 17, S93–S95 (1998).
Taira, A.V. Emerg. Infect. Dis. 10, 1915–1923 (2004).
Clemens, J., Brenner, R., Rao, M., Tafari, N. & Lowe, C. JAMA 275, 390–397 (1996).
Clements, C.J., Abdool-Karim, Q., Chang, M.L., Nkowane, B. & Esparza, J. Vaccine 22, 2822–2826 (2004).
DeRoeck, D., Nyamete, A., Mahoney, R. & Clemens, J. Vaccine 22, 121–129 (2003).
Mahoney, R. J. Health Popul. Nutr. 22, 331–337 (2004).
Clemens, J & Jodar, L. J. Health Popul. Nutr. 22, 223–231 (2004).
Levine, O., Cherian, T., Shah, R. & Batson, A. J. Health Popul. Nutr. 22, 268–274 (2004).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Clemens, J., Jodar, L. Introducing new vaccines into developing countries: obstacles, opportunities and complexities. Nat Med 11 (Suppl 4), S12–S15 (2005). https://doi.org/10.1038/nm1225
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1225
This article is cited by
-
How a New Health Intervention Affects the Health Systems? Learnings from Pentavalent Vaccine Introduction in India
The Indian Journal of Pediatrics (2016)
-
Nanotechnology in Vaccine Development
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences (2012)
-
The potential impact of immunization campaign budget re-allocation on global eradication of paediatric infectious diseases
BMC Public Health (2011)
-
Issues in the design and implementation of vaccine trials in less developed countries
Nature Reviews Drug Discovery (2006)